Cargando…

Obstacles and Recommendations for Clinical Translation of Nanoparticle System-Based Targeted Alpha-Particle Therapy

The rationale for application of nanotechnology in targeted alpha therapy (TAT) is sound. However, the translational strategy requires attention. Formulation of TAT in nanoparticulate drug delivery systems has the potential to resolve many of the issues currently experienced. As α-particle emitters...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kleynhans, Janke, Sathekge, Mike, Ebenhan, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432563/ https://www.ncbi.nlm.nih.gov/pubmed/34500873 http://dx.doi.org/10.3390/ma14174784

Ejemplares similares

A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma
por: Bolcaen, Julie, et al.
Publicado: (2021)

A toxicity profile of the Pheroid® technology in rodents
por: Kleynhans, Janke, et al.
Publicado: (2019)

An Overview of Targeted Alpha Therapy with (225)Actinium and (213)Bismuth
por: Morgenstern, Alfred, et al.
Publicado: (2018)

Towards Facile Radiolabeling and Preparation of Gallium-68-/Bismuth-213-DOTA-[Thi(8), Met(O(2))(11)]-Substance P for Future Clinical Application: First Experiences
por: Suthiram, Janine, et al.
Publicado: (2021)

Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi(8),Met(O(2))(11)]-Substance P
por: Suthiram, Janine, et al.
Publicado: (2023)

Antimicrobial Peptides: Their Role as Infection-Selective Tracers for Molecular Imaging
por: Ebenhan, Thomas, et al.
Publicado: (2014)

Perspective on the Use of DNA Repair Inhibitors as a Tool for Imaging and Radionuclide Therapy of Glioblastoma
por: Everix, Liesbeth, et al.
Publicado: (2022)

Lost in Translation: Obstacles to Translational Medicine
por: Mankoff, Stacey P, et al.
Publicado: (2004)

(213)Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer
por: Sathekge, Mike, et al.
Publicado: (2017)

Preclinical Assessment of a (68)Ga-DOTA-Functionalized Depsipeptide as a Radiodiagnostic Infection Imaging Agent
por: Ebenhan, Thomas, et al.
Publicado: (2017)

Nanocarriers for Stroke Therapy: Advances and Obstacles in Translating Animal Studies
por: Alkaff, Syed Abdullah, et al.
Publicado: (2020)

Global experience with PSMA-based alpha therapy in prostate cancer
por: Sathekge, Mike M., et al.
Publicado: (2021)

Current and future therapies for SLE: obstacles and recommendations for the development of novel treatments
por: Touma, Zahi, et al.
Publicado: (2017)

Nanoparticles in Targeted Alpha Therapy
por: Majkowska-Pilip, Agnieszka, et al.
Publicado: (2020)

Identifying and hurdling obstacles to translational research
por: Sabroe, Ian, et al.
Publicado: (2007)

(68)Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans
por: Sathekge, Mike, et al.
Publicado: (2017)

(68)Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients
por: Sathekge, Mike, et al.
Publicado: (2016)

Overcoming the obstacles of current photodynamic therapy in tumors using nanoparticles
por: Lee, Donghyun, et al.
Publicado: (2021)

Editorial: Targeted alpha particle therapy in oncology
por: Bruland, Øyvind Sverre, et al.
Publicado: (2023)

Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection
por: Huang, Xuhao, et al.
Publicado: (2022)

Development of a Single Vial Kit Solution for Radiolabeling of (68)Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients
por: Ebenhan, Thomas, et al.
Publicado: (2015)

Visualizations in particle physics – Learning aids or obstacles
por: Zochling, Sarah Maria
Publicado: (2018)

Visualizations in particle physics - Learning aids or obstacles?
por: Zoechling, Sarah Maria
Publicado: (2019)

The determination of the radiochemical purity of Actinium-225 radiopharmaceuticals: a conundrum
por: Kleynhans, Janke, et al.
Publicado: (2022)

Development of Targeted Alpha Particle Therapy for Solid Tumors
por: Tafreshi, Narges K., et al.
Publicado: (2019)

Emergency situations and deaf people in Israel: Communication obstacles and recommendations
por: Tannenbaum-Baruchi, Carolina, et al.
Publicado: (2014)

Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
por: Everix, Liesbeth, et al.
Publicado: (2023)

Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle
por: Dekempeneer, Yana, et al.
Publicado: (2016)

Anoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma?
por: Dewdney, Brittany, et al.
Publicado: (2022)

Probing the biological obstacles of nanomedicine with gold nanoparticles
por: Li, Bin, et al.
Publicado: (2018)

Opportunities and obstacles in microbial synthesis of metal nanoparticles
por: Carmona, Manuel, et al.
Publicado: (2023)

Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research
por: You, Liting, et al.
Publicado: (2019)

Implementing blind proficiency testing in forensic laboratories: Motivation, obstacles, and recommendations
por: Mejia, Robin, et al.
Publicado: (2020)

Obstacles to Exercising Reproductive Rights for Single Women in China and Legal Recommendations
por: Li, Taoying, et al.
Publicado: (2023)

Targeting Prostate Cancer Stem Cells with Alpha-Particle Therapy
por: Ceder, Jens, et al.
Publicado: (2017)

Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma
por: Bell, Meghan M., et al.
Publicado: (2020)

Targeted Alpha-Particle Therapy: A Review of Current Trials
por: Jang, Albert, et al.
Publicado: (2023)

Fundamentals of Rhenium-188 Radiopharmaceutical Chemistry
por: Kleynhans, Janke, et al.
Publicado: (2023)

Unleashing the cure: Overcoming persistent obstacles in the translation and expanded use of hematopoietic stem cell‐based therapies
por: Talib, Sohel, et al.
Publicado: (2020)

Inert nanoparticle suppression of gas explosion in the presence of obstacles
por: Wen, Xiaoping, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v9qb8g2ig63v83l5sqpiqjhoi4